Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Viramune receives accelerated FDA approval

June 28, 1996

Merck & Co. claims process for synthesizing HIV protease inhibitors

June 28, 1996

Y-ART-3: Promising HIV treatment candidate

June 21, 1996

HIV protease inhibitors from Warner-Lambert

June 21, 1996

Alpha-glucosidase inhibitors from Seikagaku Kogyo

June 21, 1996

Pediatric clinical trials for Remune commence

June 14, 1996

GR-92754: Most effective DHFR inhibitor

June 14, 1996

Alferon LDO enters clinical trials

June 14, 1996

Additional AIDS gene therapy phase II trial

June 14, 1996

Rescriptor available through Canadian expanded access program

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...